ClinicalTrials.Veeva

Menu

Polymorphids an mRNA Expression in Obese Genes

Karolinska Institute logo

Karolinska Institute

Status

Completed

Conditions

Polymorphism
mRNA Expression

Study type

Observational

Funder types

Other

Identifiers

NCT01708083
2009/1629-31/3

Details and patient eligibility

About

Fat tissue from omenta, thigh and abdomen taken under anesthesia on subjects undergoing laparoscopic surgery, cholecystectomy, reflux surgery or gastric by-pass (GBP).

Are there any difference in polymorphids and/or mRNA expression in genes significant for developing obesity, between normal weight and obese individuals, with or without diabetes typ 2 .

Are there any difference in polymorphids and/or mRNA expression in different types of fat tissue

Enrollment

50 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18 years or older
  • laparoscopic surgery (Gastric by-pass, cholecystectomy, antireflux surgery)
  • Normal weight without type 2 diabetes BMI 18-25
  • Obese without type 2 diabetes BMI>35
  • Obese with type 2 diabetes BMI>35

Exclusion criteria

  • under 18 years
  • open surgery
  • pregnancy
  • BMI >27-<35

Trial design

50 participants in 3 patient groups

Type 2 Diabetes and BMI>35
Description:
Patients with type 2 diabetes and body mass index 35 or more.
BMI>35
Description:
Patients undergoing surgery, gastric bypass or cholecystectomy, without diabetes type 2 and body mass index 35 or more
BMI 18-27
Description:
Patients undergoing surgery, cholecystectomy or reflux, without type 2 diabetes and body mass index between 18-27

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems